Deepika Sharma¹* and Nimali Singh²

¹Research Scholar, Department of Home Science, University of Rajasthan, Jaipur, India
²Associate Professor, Department of Home Science, University of Rajasthan, Jaipur, India

*Corresponding Author: Deepika Sharma, Research Scholar, Department of Home Science, University of Rajasthan, Jaipur, India.

Received: July 08, 2021; Published: August 28, 2021

Abstract

Introduction: Dyslipidemia is measured to be one among the 5 top most threatening factors for cardio-vascular diseases, along with hypertension, diabetes mellitus, smoking and obesity. Plant seeds like flax seeds are easy to consume and more effective in dyslipidemic patients. Therefore, this study is intended to conclude whether flax seed powder has any dose response on clinical variables associated with dyslipidemia in dyslipidemic patients.

Aim: To study the impact of supplementation of flax seed powder on the lipid levels as well as on the nutritional status of dyslipidemic patients.

Methodology: A private hospital, Galaxy Specialty Centre, Jaipur was selected to conduct the study. Total 100 dyslipidemic patients of age between 30 and 55 years were selected and 50 patients were given flax seed powder 15 grams per day for three months and 50 patients were kept as control. Anthropometric measurements and biochemical estimations were measured at pre and post intervention.

Results: After three months of supplementation with flax seed powder, there were significant improvements observed in the anthropometric measurements like weight, waist, hip circumference and BMI of the dyslipidemic patients. However, no changes were observed in control group. The lipid levels of the experimental group were found to be reduced significantly. The high density lipoprotein cholesterol was also increased in experimental group whereas in control group it was almost same.

Conclusion: The results indicate that intervention with flax seed powder may be regarded a useful remedial food for the management of dyslipidemia.

Keywords:Dyslipidemia; Total Cholesterol; Low Density Lipoprotein Cholesterol; Triglycerides; High Density Lipoprotein Cholesterol; Flax Seeds; Body Mass Index

References

1. Terzic A and Waldman S. “Chronic Diseases: The Emerging Pandemic”. Clinical and Translational Science3 (2011): 225-226.
2. Gupta A., et al. “Prevalence of diabetes and cardiovascular risk factors in middleclass urban participants in India”. BMJ Open Diabetes Research and Care 2 (2014): e000048.
3. Sharma Y K., et al. “Prevalence of risk factors for coronary artery disease in an urban Indian Population”. BMJ Open 4 (2014): e005346.
4. Goldberg AC. Dyslipidemia. MSD, Professional Version, www.msdmanual.com (2015).
5. İlhan C., et al. “Serum lipid and lipoprotein levels, dyslipidemia prevalence, and the factors that influence these parameters in a Turkish population living in the province of Tokat”. Turkish Journal of Medical Sciences 5 (2010): 771-782.
6. Pan L., et al. “The prevalence, awareness, treatment and control of dyslipidemia among adults in China”. China National Survey of Chronic Kidney Disease Working Group Elsevier. Atherosclerosis 248 (2016): 2-9.
7. Wang S., et al. “High Prevalence and associated factors of dyslipidemiain the adult chinese population”. Plos ONE I-3 (2011): e17326.
8. Joffres M D., et al. “Dyslipidemia Prevalence, Treatment, Control, and Awareness in the Canadian Health Measures Survey”. Canadian Journal of Public Health 104 (2013): 252-e257.
9. Bayram F., et al. “Prevalence of dyslipidemia and associated risk factors in Turkish adults”. Journal of Clinical Lipidology 2 (2014): 206-216.
10. Sharma U., et al. “Dyslipidemia and associated risk factors in a resettlement colony of Delhi”. Journal of Clinical Lipidology6 (2013): 653-660.
11. Tripathy J P., et al. “Burden and risk factors of dyslipidemia-results from a STEPS survey in Punjab India Diabetes and Metabolic Syndrome”. Clinical Research and Reviews1 (2017): S21-S27.
12. Das H and Banik S. “Prevalence of dyslipidemia among the diabetic patients in southern Bangladesh: A cross-Sectional Study”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy1 (2019): 252-257.

Citation

Citation: Deepika Sharma and Nimali Singh. “Impact of Flax Seed Powder Supplementation on the Anthropometry and Bio-chemical Parameters of Dyslipidemic Patients".Acta Scientific Nutritional Health 5.9 (2021): 54-57.

Copyright

Copyright: © 2021 Deepika Sharma and Nimali Singh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.